Lymphocytes treated by extracorporeal photopheresis demonstrate a drop in the Bcl-2/Bax ratio: A possible mechanism involved in extracorporeal-photopheresis-induced apoptosis

被引:16
作者
Bladon, J [1 ]
Taylor, PC [1 ]
机构
[1] Rotherham Hosp, Dept Haematol, Rotherham S60 2UD, S Yorkshire, England
关键词
photopheresis; Bcl-2; Bax; apoptosis; flow cytometry;
D O I
10.1159/000051826
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Recently, apoptosis has been identified in treated lymphocytes, prior to their re-infusion, when tested ex vivo. Previous work has demonstrated a close association between the genes p53, Bcl-2 and Bax and apoptosis induced by UV irradiation. Objectives: We wanted to establish whether the expression of the protein product of these genes was altered in lymphocytes treated with extracorporeal photopheresis (ECP) prior to re-infusion and therefore possibly implicated in the early apoptosis observed. Method. Lymphocytes were isolated immediately before treatment and immediately prior to re-infusion and tested for intracellular levels of p53, Bcl-2 and Bax proteins. Results: No increase in p53 expression was observed at re-infusion; however, the mean fluorescent intensity ratio of the apoptotic inhibitor protein Bcl-2 to the apoptosis-inducing protein Bax dropped significantly. Conclusion: The early apoptosis observed in ECP-treated lymphocytes at re-infusion might be attributed to dysregulation in the expression of the apoptotic genes Bcl-2 and Bax. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:104 / 107
页数:4
相关论文
共 24 条
[11]   p53 - An acrobat in tumorigenesis [J].
Moll, UM ;
Schramm, LM .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1998, 9 (01) :23-37
[12]   Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells [J].
Nielsen, M ;
Kæstel, CG ;
Eriksen, KW ;
Woetmann, A ;
Stokkedal, T ;
Kaltoft, K ;
Geisler, C ;
Röpke, C ;
Odum, N .
LEUKEMIA, 1999, 13 (05) :735-738
[13]   BCL-2 HETERODIMERIZES IN-VIVO WITH A CONSERVED HOMOLOG, BAX, THAT ACCELERATES PROGRAMMED CELL-DEATH [J].
OLTVAI, ZN ;
MILLIMAN, CL ;
KORSMEYER, SJ .
CELL, 1993, 74 (04) :609-619
[14]   The binding properties and biological activities of Bcl-2 and Bax in cells exposed to apoptotic stimuli [J].
Otter, I ;
Conus, S ;
Ravn, U ;
Rager, M ;
Olivier, R ;
Monney, L ;
Fabbro, D ;
Borner, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (11) :6110-6120
[15]   THERAPEUTIC APPLICATIONS OF PHOTOPHERESIS [J].
ROOK, AH ;
COHEN, JH ;
LESSIN, SR ;
VOWELS, BR .
DERMATOLOGIC CLINICS, 1993, 11 (02) :339-347
[16]   Photopheresis: Clinical applications and mechanism of action [J].
Rook, AH ;
Suchin, KR ;
Kao, DMF ;
Yoo, EK ;
Macey, WH ;
DeNardo, BJ ;
Bromely, PG ;
Geng, YM ;
Junkins-Hopkins, JM ;
Lessin, SR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 1999, 4 (01) :85-90
[17]   Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c [J].
Rossé, T ;
Olivier, R ;
Monney, L ;
Rager, M ;
Conus, S ;
Fellay, I ;
Jansen, B ;
Borner, C .
NATURE, 1998, 391 (6666) :496-499
[18]  
VanderVliet HJJ, 1997, CLIN EXP IMMUNOL, V110, P324
[19]   Differential regulation of p53 and Bcl-2 expression by ultraviolet A and B [J].
Wang, Y ;
Rosenstein, B ;
Goldwyn, S ;
Zhang, XS ;
Lebwohl, M ;
Wei, HC .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (03) :380-384
[20]  
Wyllie A H, 1980, Int Rev Cytol, V68, P251